CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk Healthcare Bliss GVS Pharma Ltd

Bliss GVS Pharma Ltd

BSE 506197 BLISSGVS INE416D01022
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

36 filings · 4 material · busiest 2026-06-23

What it files

Filings

36 in the window

  1. 25 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed herewith the Newspaper Publication regarding the extension of the Special Window for Re-Lodgement of Transfer Request of Physical Shares.

    Company Update / Newspaper Publication View filing →

  2. 21 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed herewith the Newspaper Publication regarding the publication of the advertisement for the Postal Ballot Notice.

    Company Update / Newspaper Publication View filing →

  3. 20 August 2026

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    Please find enclosed herewith the Postal Ballot Notice ("Notice") dated August 12, 2026, alongwith the Explanatory Statement for seeking approval of Members of the Company by way of remote ....

    AGM/EGM / Postal Ballot View filing →

  4. 14 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed herewith the copies of newspaper advertisement published regarding the extract of statement of Un-audited Standalone and Consolidated Financial Results of the Company ....

    Company Update / Newspaper Publication View filing →

  5. 12 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 12, 2026

    We wish to inform you that the Board Meeting of the Company was held today i.e. on Wednesday, August 12, 2026, through Video Conferencing ("VC")/Other Audio-Visual Means ("OAVM"), with ....

    Board Meeting / Outcome of Board Meeting View filing →

  6. 12 August 2026

    Results

    Outcome Of Board Meeting Held On Wednesday, August 12, 2026

    We wish to inform you that the Board Meeting of the Company was held today i.e. on Wednesday, August 12, 2026 through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM") with ....

    Result / Financial Results View filing →

  7. 12 August 2026

    General

    Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019

    Please find enclosed herewith the outcome of Members of the Nomination and Remuneration Committee of Bliss GVS Pharma Limited ("the Company")in its meeting held today i.e. on August 12, ....

    Company Update / General View filing →

  8. 11 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  9. 11 August 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    We would like to inform you that the ESOP Allotment Committee of the Company at its meeting held today i.e. August 11, 2026 has approved the allotment of 31, 250 equity shares of the face ....

    Company Update / Allotment of ESOP / ESPS View filing →

  10. 5 August 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, August 12, 2026

    Bliss GVS Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....

    Board Meeting / Board Meeting View filing →

  11. 27 July 2026

    General

    Pre-Offer Advertisement & Corrigendum to Detailed Public Statement

    SBI Capital Markets Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of the Securities and Exchange Board of ....

    Company Update / General View filing →

  12. 24 July 2026

    KMP

    Cessation

    Please find attached detailed intimation regarding resignation of Mr. Sachin Saboo, Senior Management Personnel of the Company, pursuant to Regulation 30 of SEBI (Listing Obligations and ....

    Company Update / Cessation View filing →

  13. 23 July 2026

    General

    Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend 2018-2019 And Its Corresponding Shares To Investor Education And Protection Fund (IEPF) Authority

    Please find enclosed herewith the Notice sent to shareholders w.r.t. the transfer of Unclaimed Final Dividend 2018-2019 and its corresponding shares to the IEPF Authority.

    Company Update / General View filing →

  14. 23 July 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached copies of the newspaper publications containing recommendation of the Committee of Independent Directors.

    Company Update / Newspaper Publication View filing →

  15. 22 July 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed herewith the Newspaper publication regarding Notice to Shareholders for Transfer of Unclaimed Final Dividend 2018-2019 and its corresponding Equity Shares to IEPF.

    Company Update / Newspaper Publication View filing →

  16. 22 July 2026

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Clarus Capital I & Others

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  17. 22 July 2026

    General

    Intimation Of Recommendations By The Committee Of Independent Directors ('IDC') Pursuant To Regulation 26(7) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

    Please find attached the intimation of recommendations by the Committee of Independent Directors pursuant to Regulation 26(7) of the SEBI (Substantial Acquisition of Shares and Takeovers) ....

    Company Update / General View filing →

  18. 21 July 2026

    General

    Letter Of Offer Dated July 18, 2026 Received From SBI Capital Markets Limited

    Letter of Offer dated July 18, 2026 received from SBI Capital Markets Limited, the manager to the Open Offer appointed by Anupam Rasayan India Limited along with PAC.

    Company Update / General View filing →

  19. 15 July 2026

    General

    Contact Details Of Kmps For Reporting Of Material Events To Stock Exchanges

    Please find enclosed herewith the details of KMPs for reporting Disclosure of Material Events to Stock Exchanges.

    Company Update / General View filing →

  20. 15 July 2026

    AGM / EGM

    Proceedings Of 41St Annual General Meeting Of Bliss GVS Pharma Limited

    Please find attached herewith the proceedings of 41st Annual General Meeting of Bliss GVS Pharma Limited.

    AGM/EGM / AGM View filing →

  21. 15 July 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Please find enclosed herewith the Voting Results alongwith the Scrutinizer Report for the 41st Annual General Meeting of the Company held on Wednesday, July 15, 2026.

    AGM/EGM / AGM View filing →

  22. 7 July 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    We like to inform you that the ESOP Allotment Committee of the Company at its meeting held today i.e. July 07, 2026 has approved the allotment of 1,87,750 equity shares of the face value ....

    Company Update / Allotment of ESOP / ESPS View filing →

  23. 3 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please find enclosed herewith the Certificate under Regulation 74(5) of the SEBI (D&P) Regulations 2018, for the quarter ended June 30, 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  24. 3 July 2026

    Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, July 03, 2026

    Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that based on the recommendation ....

    Others / Outcome without intimation View filing →

  25. 3 July 2026

    Change in Management

    Change in Management

    Enclosed herewith is the intimation regarding the Change in Management of the Company.

    Company Update / Change in Management View filing →

  26. 29 June 2026

    Trading Window

    Closure of Trading Window

    Please find enclosed herewith the Intimation regarding the closure of the Trading Window for the quarter ended June 30, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →

  27. 24 June 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed herewith the Newspaper Advertisement published regarding Notice of 41st Annual General Meeting, E-voting and Book Closure Information.

    Company Update / Newspaper Publication View filing →

  28. 23 June 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), please find ....

    Others / Reg. 34 (1) Annual Report View filing →

  29. 23 June 2026

    AGM / EGM

    Notice Of The 41St Annual General Meeting ('41St AGM') Of Bliss GVS Pharma Limited

    Please find enclosed herewith the Notice of 41st AGM of Bliss GVS Pharma Limited ("the Company") scheduled to be held on Wednesday, July 15, 2026, at 11:00 A.M. (IST) through VC/OAVM. The ....

    AGM/EGM / AGM View filing →

  30. 23 June 2026

    Book Closure

    Intimation Of Book Closure In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

    Please find enclosed herewith the intimation for the Book Closure for the purpose of 41st Annual General Meeting of the Company.

    Corp. Action / Book Closure View filing →

  31. 23 June 2026

    Record Date

    Intimation Of Record Date In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

    Please find enclosed herewith the intimation regarding the Fixation of the record date for the payment of the final dividend for the financial year ended March 31, 2026.

    Corp. Action / Record Date View filing →

  32. 19 June 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed herewith the Newspaper publication regarding the 41st Annual General Meeting of the Company.

    Company Update / Newspaper Publication View filing →

  33. 19 June 2026

    General

    Communication To Shareholders - Intimation Of Tax Deduction On Dividend

    Please find enclosed herewith the communication sent to shareholders regarding Intimation of Tax Deduction on Dividend.

    Company Update / General View filing →

  34. 11 June 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. June 11, 2026 has approved the allotment of 267250 equity shares of face value Re.1/- each to ....

    Company Update / Allotment of ESOP / ESPS View filing →

  35. 9 June 2026

    General

    Draft Letter of Offer

    SBI Capital Markets Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Bliss GVS Pharma Ltd ("Target Company").

    Company Update / General View filing →

  36. 9 June 2026

    General

    Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

    Please find attached a copy of the Draft Letter of Offer (DLOF) from SBI Capital Markets Limited, the Manager to the Open Offer.

    Company Update / General View filing →